1998
DOI: 10.1152/ajpregu.1998.274.1.r255
|View full text |Cite
|
Sign up to set email alerts
|

Salt-sensitive hypertension in ANP knockout mice: potential role of abnormal plasma renin activity

Abstract: Atrial natriuretic peptide (ANP), a peptide hormone produced by the heart, exerts a chronic hypotensive effect. Knockout mice with a homozygous disruption of the pro-ANP gene (−/−) are incapable of producing ANP and are hypertensive relative to their wild-type (+/+) siblings. Previous studies showed that arterial blood pressure (ABP) was further increased in conscious −/− mice kept for 2 wk on 2% salt, but not in anesthetized −/− mice after 1 wk on 8% salt. To determine whether inconsistencies in observed effe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
37
0

Year Published

1999
1999
2014
2014

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 50 publications
(39 citation statements)
references
References 37 publications
2
37
0
Order By: Relevance
“…48,57,58 Treatments that prevent or limit the response of this system (for example, administration of a mineralocorticoid agonist such as desoxycorticosterone acetate, infusion of exogenous angiotensin II or removal of kidney mass, which limits the upper range of renal salt-excreting capacity) have often been used to increase the acute salt sensitivity of experimental animals. In a similar manner, the impairment of any other system that normally contributes to the ability of renal sodium excretion to adapt to a new level of salt intake (for example, atrial natriuretic peptide, 59 sympathetic activity [60][61][62][63] and nitric oxide 64 ) is also expected to promote salt sensitivity of blood pressure.…”
Section: -42mentioning
confidence: 99%
“…48,57,58 Treatments that prevent or limit the response of this system (for example, administration of a mineralocorticoid agonist such as desoxycorticosterone acetate, infusion of exogenous angiotensin II or removal of kidney mass, which limits the upper range of renal salt-excreting capacity) have often been used to increase the acute salt sensitivity of experimental animals. In a similar manner, the impairment of any other system that normally contributes to the ability of renal sodium excretion to adapt to a new level of salt intake (for example, atrial natriuretic peptide, 59 sympathetic activity [60][61][62][63] and nitric oxide 64 ) is also expected to promote salt sensitivity of blood pressure.…”
Section: -42mentioning
confidence: 99%
“…ANFexhibits vasodilation, suppression of plasma renin activity, inhibition of the synthesis and release of aldosterone, and promotes diuresis and natriuresis. In experimental models, ANPknockout mice develop salt-sensitive hypertension (63,64) in part due to their inability to reduce plasma renin activity (64). On the other hand, disruption of the guanylate cyclase-A gene results in salt-resistant hypertension in mice (65).…”
Section: Atrial Natriuretic Factor or Peptidementioning
confidence: 99%
“…Disruption of the murine NPR-A gene resulted in salt-resistant hypertension, cardiac hypertrophy, and fibrosis (10)(11)(12). Gene targeting of ANP led to salt-sensitive hypertension and cardiac hypertrophy, whereas BNP knockout mice exhibited a marked cardiac fibrosis without hypertension or hypertrophy (13)(14)(15).…”
mentioning
confidence: 99%